Corrigendum

The authors of “Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration” (Ophthalmology 2016;123:2545-2553) would like to add the following financial statement to their acknowledgements section:
Source: Ophthalmology - Category: Opthalmology Tags: Corrigendum Source Type: research